GLP-1 Weight Management
FDA-Approved Weight Loss Therapy
Semaglutide is a GLP-1 receptor agonist that helps regulate appetite, slow gastric emptying, and support sustainable weight loss when combined with diet and exercise. Available in three concentrations to match your treatment phase.
15%
Avg Body Weight Loss
68
Week Clinical Trial
1x
Weekly Injection
22+
BHRC Locations
Choose Your Formulation
We offer three concentrations to support you from initial titration through long-term maintenance. Your physician will recommend the best option based on your treatment phase.
5mg per vial
Ideal For
New patients beginning semaglutide therapy who need lower doses during the titration period.
10mg per vial
Ideal For
Patients who have completed titration and are on therapeutic doses during active weight loss.
20mg per vial
Ideal For
Patients on maximum dose (2.4mg) or those preferring fewer refills with extended supply.
The Science
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a hormone naturally produced in your gut after eating. This hormone signals your brain to feel satisfied, reduces appetite, and slows the rate at which food leaves your stomach.
Originally developed for type 2 diabetes management, semaglutide demonstrated such significant weight loss effects that the FDA approved it specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
At BHRC, our physicians prescribe semaglutide as part of comprehensive programs that include nutrition counseling, lifestyle guidance, and ongoing monitoring to help you achieve and maintain your goals.
Book a Consultation
How It Works
Semaglutide works through multiple pathways to support sustainable weight loss.
Activates receptors in the brain that control hunger and satiety, helping you feel satisfied with smaller portions and reducing cravings between meals.
Delays stomach emptying so food stays in your system longer. This prolongs feelings of fullness and helps prevent overeating at subsequent meals.
Stimulates insulin release when blood sugar rises and reduces glucagon secretion, helping maintain stable glucose levels throughout the day.
Clinical Benefits
Clinical trials showed participants lost an average of 15% of their body weight over 68 weeks—significantly more than diet and exercise alone.
Works with your body’s natural hunger signals to reduce cravings and help you feel satisfied with smaller portions.
May improve blood sugar control, blood pressure, and cholesterol levels—benefits that extend beyond weight loss alone.
Studies indicate reduced risk of major cardiovascular events in adults with obesity and established heart disease.
Just one injection per week—simple to incorporate into your routine without daily medications or complicated schedules.
When combined with lifestyle changes, helps establish healthier eating patterns that can be maintained long-term.
Your Journey
Our medical team guides you through every step—from initial consultation to ongoing optimization.
Meet with our physician to discuss goals, review health history, and determine if semaglutide is right for you.
Complete necessary bloodwork to ensure you can safely begin treatment and establish your baseline.
Start at a low dose (S5) that gradually increases over weeks to minimize side effects and optimize results.
Regular check-ins to monitor progress, adjust dosing (S10/S20), and provide nutrition guidance.
Safety & Candidacy
Semaglutide is FDA-approved for adults with a BMI of 30 or higher, or 27+ with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol.
2021
FDA approval for chronic weight management in adults
STEP
Comprehensive clinical trial program with thousands of participants
Questions
S5, S10, and S20 refer to the total milligrams of semaglutide per vial (5mg, 10mg, and 20mg). S5 is typically used during initial titration when doses are lower (0.25–0.5mg weekly). S10 is most common during active treatment at therapeutic doses (1.0–1.7mg). S20 is for patients on maximum dose (2.4mg) or those preferring extended supply with fewer refills. Your physician will recommend the appropriate formulation based on your treatment phase.
Semaglutide is administered as a once-weekly subcutaneous injection. Our clinical team will teach you proper technique during your initial visit. Most patients find the injections quick and relatively painless after a short learning curve.
In clinical trials, participants lost an average of 15% of their body weight over 68 weeks. Individual results vary based on starting weight, diet, exercise, and adherence to the program. Most patients begin noticing reduced appetite within the first few weeks, with significant weight loss typically occurring during months 3–6 at therapeutic doses.
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These typically occur during dose increases and improve over time. Starting at a low dose (S5) and gradually increasing helps minimize these effects. Our team monitors you throughout treatment to manage any side effects.
Semaglutide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. It should not be used during pregnancy or breastfeeding. Our physicians will review your complete health history during consultation to ensure this treatment is appropriate for you.
Semaglutide is typically prescribed as a long-term treatment. Studies show that weight regain is common when the medication is discontinued without sustained lifestyle changes. Our team works with you to develop habits that support your results, whether you continue on maintenance doses (often S10 or S20) or eventually transition off therapy.
Most patients progress through formulations as their treatment advances. You’ll likely start with S5 during the titration period (first 4–8 weeks), then move to S10 once at therapeutic doses. Some patients transition to S20 when on maximum dose or for the convenience of extended supply. Your physician guides these transitions based on your progress and needs.
Get Started
Schedule a consultation with our medical team to learn which semaglutide formulation is right for your health goals.
"*" indicates required fields
Or call us directly: 1-800-XXX-XXXX
*Semaglutide is FDA-approved for chronic weight management in adults with a BMI ≥30, or ≥27 with at least one weight-related condition. Individual results may vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. A consultation with our medical team is required to determine if this therapy is appropriate for you.
